What is Anika Therapeutics's net income?

Anika Therapeutics (ANIK) reported net income of -$5.06M in Q1 2026.

How has Anika Therapeutics's net income changed year-over-year?

Anika Therapeutics's net income decreased by 3.8% year-over-year, from -$4.87M to -$5.06M.

What is the long-term trend for Anika Therapeutics's net income?

Over 3 years (2022 to 2025), Anika Therapeutics's net income has grown at a -9.1% compound annual growth rate (CAGR), from -$14.86M to -$11.17M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Anika Therapeutics ANIK Net Income

Net Income at other companies

StrykerSYK

$745M+13.9%

VericelVCEL

-$6.3M+44.0%

Pacira BioSciences, Inc.PCRX

$2.92M-39.4%

BioventusBVS

$3.95M+219%

Xtant Medical HoldingsXTNT

-$3.09M-5,426%

Globus MedicalGMED

$124.3M+64.7%

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's net income?: Anika Therapeutics (ANIK) reported net income of -$5.06M in Q1 2026.
How has Anika Therapeutics's net income changed year-over-year?: Anika Therapeutics's net income decreased by 3.8% year-over-year, from -$4.87M to -$5.06M.
What is the long-term trend for Anika Therapeutics's net income?: Over 3 years (2022 to 2025), Anika Therapeutics's net income has grown at a -9.1% compound annual growth rate (CAGR), from -$14.86M to -$11.17M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.